We are analysing your feedback
Visit this page again soon to download the outcome to this public feedback.
The Patient Capital Review outlined how many knowledge-intensive companies, which typically have a high proportion of R&D expenditure and are often innovating or creating intellectual property, struggle particularly to receive the capital they need to grow and scale up. In response to the review the government announced an action plan to unlock £20 billion of investment in innovative firms over ten years which included a number of extensions and reforms of the venture capital schemes (Enterprise Investment Scheme, Seed Enterprise Investment Scheme, Venture Capital Trusts).
As part of the Patient Capital Review reforms to promote high-growth and innovative investment the government is consulting on the introduction of a new approved fund structure within the Enterprise Investment Scheme, with the possibility of additional incentives to attract investment. Such a fund structure would be focused on mainly investing in knowledge-intensive companies. This consultation outlines and seeks views on possible elements and constraints of such a fund structure, while also seeking to better understand the capital requirements of innovative knowledge-intensive companies.